glp-1 naion risk
The 3-Step Semaglutide Protocol NAION Ignores
In a 2023 retrospective study linking GLP-1 drugs to a rare optic nerve loss, no formal ophthalmology protocol was offered, leaving clinicians without a clear pathway to screen for NAION in patients on semaglutide. The gap persists despite growing use of GLP-1 agents for obesity and diabetes. Medical Disclaimer: This